Baricitinib vs Gefitinib

Baricitinib vs Gefitinib: Overview

This comparison examines the pharmacological differences between Baricitinib and Gefitinib.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Gefitinib — 48 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Gefitinib — C22H24ClFN4O3.

Molecular Weight: Baricitinib — 371.4170 g/mol; Gefitinib — 446.9000 g/mol.

Type: Baricitinib — Small molecule; Gefitinib — Small molecule.